TMEM120A Antibody

What is TMEM120A and what are its known cellular functions?

TMEM120A (Transmembrane protein 120A) is a highly conserved vertebrate membrane protein that forms homodimers with each monomer containing an N-terminal coiled-coil domain (CCD) followed by a transmembrane domain (TMD) with six membrane-spanning helices . It was initially identified as a nuclear envelope transmembrane protein (NET29) .

TMEM120A has been implicated in several cellular functions:

• Adipocyte differentiation and metabolism (particularly expressed in adipose tissue)

• Initially proposed as a mechanosensitive ion channel (TACAN) involved in sensing mechanical pain, though this function has been questioned by recent structural studies

• Potential involvement in fatty acid metabolism based on structural similarities to elongase for very long-chain fatty acids (ELOVL)

• Coenzyme A (CoA) binding and potential roles in CoA transport, sensing, or metabolism

Recent cryo-EM structural studies have shown that TMEM120A's transmembrane domain lacks clear ion channel features but instead contains a deep pocket that binds CoA .

What is the molecular structure of human TMEM120A protein?

Human TMEM120A is a 343 amino acid protein with a molecular weight of approximately 40.6 kDa . Structurally, as revealed by cryo-EM studies, TMEM120A forms a tightly packed dimer with each monomer containing:

• An N-terminal coiled-coil domain (CCD) with two helices (IH1 and IH2)

• A re-entrant loop connecting the domains

• A C-terminal transmembrane domain (TMD) containing six transmembrane helices (TMs) that form an α-barrel

The dimerization of TMEM120A involves extensive interactions mediated by:

• The N-terminal coiled-coil domain, where the exceptionally long CC1 helix forms an anti-parallel coiled coil with CC1 from the neighboring subunit

• The re-entrant loop between domains

• The transmembrane domain at the external leaflet of the membrane

The six transmembrane helices form an α-barrel with a deep pocket where a coenzyme A (CoA) molecule binds . This structural feature suggests potential enzymatic functions rather than ion channel activity.

How should I select the appropriate TMEM120A antibody for my specific application?

Selecting the optimal TMEM120A antibody requires consideration of several experimental factors:

Additional selection criteria to consider:

• Target epitope: Antibodies targeting different regions (N-terminal, C-terminal, or specific domains) may yield different results. For studying the CoA-binding function, consider antibodies that don't interfere with the binding pocket .

• Species reactivity: Confirm cross-reactivity with your experimental model (human, mouse, rat, etc.) . The TMEM120A sequence is conserved across vertebrates but may have species-specific variations.

• Clonality: Monoclonal antibodies offer higher specificity but may miss splice variants; polyclonal antibodies provide broader detection but potentially higher background .

• Validation data: Review available validation evidence including Western blot images showing the expected molecular weight (35-41 kDa) and positive/negative control tissues .

What controls should I use to validate TMEM120A antibody specificity?

Thorough validation of TMEM120A antibodies is essential for reliable research outcomes:

Positive controls:

• Tissues with known TMEM120A expression (adipose tissue, liver)

• Cell lines with verified TMEM120A expression (HEK293 cells)

• Recombinant TMEM120A protein or overexpression systems

Negative controls:

• TMEM120A knockout tissues or cells (using CRISPR-Cas9 or siRNA)

• Tissues with naturally low expression

• Blocking peptide competition assays

• Secondary antibody-only controls

Advanced validation approaches:

• Orthogonal validation: Compare protein detection with mRNA expression (RT-qPCR)

• Independent antibody validation: Test multiple antibodies targeting different TMEM120A epitopes

• Genetic knockdown/knockout validation: Use TMEM120A-specific siRNA (e.g., Sigma MISSION clone TRCN0000247877) or CRISPR-edited cell lines

• Rescue experiments: Reintroduce TMEM120A into knockout systems to restore detection

Given the existence of TMEM120A paralogs (like TMEM120B) with sequence similarity, careful validation is particularly important to ensure specificity .

What are the optimal protocols for detecting TMEM120A in Western blot experiments?

For successful Western blot detection of TMEM120A, consider the following optimized protocol based on published methodologies:

Sample preparation:

• Extract proteins from tissues or cells using RIPA buffer or gentler detergents (LMNG 1% or digitonin 0.06%) for membrane protein preservation

• Include protease inhibitors to prevent degradation

• For membrane-bound TMEM120A, consider enrichment techniques such as nuclear envelope isolation

Electrophoresis and transfer:

• Load 20-50 μg protein per well

• Use 10-12% SDS-PAGE gels for optimal separation

• Expected molecular weight: 35-41 kDa

• Transfer to PVDF membrane (preferred for hydrophobic proteins)

Antibody incubation and detection:

• Block with 5% non-fat milk or 3-5% BSA in TBS-T

• Dilute primary antibody according to manufacturer recommendations (typically 1:2000-1:10000 for TMEM120A)

• Incubate overnight at 4°C

• Use appropriate HRP-conjugated secondary antibody

• For detection of multiple TMEM120A isoforms, consider longer exposure times or more sensitive detection methods

Troubleshooting common issues:

• High background: Increase blocking time or try different blocking reagents

• No signal: Verify sample preparation method preserves membrane proteins; try different epitope-targeting antibodies

• Multiple bands: Could represent different isoforms (up to 2 reported) or post-translational modifications

How can I optimize immunofluorescence protocols for detecting TMEM120A's subcellular localization?

TMEM120A has been reported in different subcellular locations including the nuclear envelope and cell membrane , making proper localization studies critical:

Fixation and permeabilization optimization:

• Test paraformaldehyde (4%) fixation (10-15 minutes) for general structure preservation

• For nuclear envelope detection, brief treatment with 0.1% Triton X-100 (5 minutes)

• For membrane visualization, gentler permeabilization with 0.1% saponin may better preserve membrane structures

Antibody incubation protocol:

• Block with 5% normal serum from the species of the secondary antibody

• Dilute primary antibody in blocking buffer (optimal dilution must be determined empirically)

• Incubate overnight at 4°C in a humid chamber

• Use fluorescently-labeled secondary antibodies appropriate for your microscopy setup

Co-localization markers:

• Nuclear envelope: Co-stain with lamin B1 or other nuclear envelope markers

• Cell membrane: Co-stain with Na+/K+ ATPase or other membrane markers

• For adipocyte studies: Consider perilipin for lipid droplet co-localization

Advanced imaging considerations:

• Super-resolution microscopy techniques can better resolve TMEM120A's precise localization at the nuclear envelope

• Live-cell imaging with fluorescently-tagged TMEM120A constructs can help study dynamics

• Use of deconvolution algorithms to improve resolution at the nuclear envelope

How can I investigate TMEM120A's coenzyme A binding function in my experimental system?

Recent structural studies have revealed that TMEM120A binds coenzyme A (CoA) , suggesting potential metabolic functions. To investigate this interaction:

Biochemical binding assays:

• Pull-down assays: Use CoA-conjugated beads to pull down TMEM120A from cell lysates

• Thermal shift assays: Monitor protein stability changes upon CoA binding

• LC-MS/MS analysis: Extract bound ligands from purified TMEM120A by methanol precipitation and analyze by mass spectrometry as described in published protocols :

  • Precipitate purified protein with methanol (4:1 ratio)

  • Vortex for 30 seconds

  • Incubate at -20°C for 20 minutes

  • Collect supernatant by centrifugation (16,400 x g, 10 min, 4°C)

  • Filter using 0.2 μm PVDF filter before MS analysis

  • Use precursor ion (PI) scan method with CoA-specific fragment ions (303 Da, 428 Da)

Mutational analysis:
Create point mutations in key CoA-binding residues, particularly the central tryptophan residue identified in structural studies . The W282A mutation has been shown to dramatically reduce CoA binding affinity .

Functional assays:

• Monitor changes in lipid metabolism in TMEM120A-overexpressing or knockout cells

• Investigate adipocyte differentiation in the presence of CoA synthesis inhibitors

• Examine TMEM120A's response to altered cellular CoA levels

What experimental approaches can resolve the contradictory findings about TMEM120A's role as a mechanosensitive ion channel versus a metabolic enzyme?

The function of TMEM120A has been controversial, with some studies proposing it as a mechanosensitive ion channel (TACAN) involved in pain sensing, while structural studies suggest enzymatic roles in metabolism . To address these contradictions:

Electrophysiological approaches:

• Patch-clamp recordings in TMEM120A-expressing cells using various mechanical stimuli (poking, stretch, osmotic shock)

• Compare wild-type TMEM120A with CoA-binding mutants to determine if CoA binding affects potential channel function

• Single-channel recordings to characterize potential ion conductance properties

Structure-function studies:

• Generate chimeric constructs between TMEM120A and known ion channels or metabolic enzymes

• Create targeted mutations to disrupt specific structural features:

  • CoA binding pocket

  • Dimerization interface

  • Transmembrane domain architecture

• Correlate structural changes with functional outputs in both channel activity and metabolic assays

Combined methodological approach:

• Calcium imaging in TMEM120A-expressing cells under mechanical stimulation

• Metabolomic profiling of TMEM120A knockout versus wild-type cells

• CRISPR-based screening to identify genetic interactions that support either function

Recent findings suggest that TMEM120A expression alone is not sufficient to mediate poking- or stretch-induced currents in cells , casting doubt on its function as a mechanosensitive channel. A comprehensive approach utilizing multiple methodologies is necessary to resolve these contradictions.

How can I address inconsistent TMEM120A antibody staining patterns in different cell types?

Researchers may observe variable TMEM120A staining patterns across different cell types due to several factors:

Potential causes of inconsistent staining:

• Variable expression levels: TMEM120A is preferentially expressed in adipose tissue but may have lower expression in other cell types

• Different subcellular localizations: TMEM120A has been reported at both the nuclear envelope and cell membrane

• Isoform variation: Up to 2 different isoforms have been reported for TMEM120A

• Epitope accessibility: Membrane protein epitopes may be differentially accessible in different cellular contexts

Troubleshooting approaches:

• Validation in multiple cell types:

  • Compare staining in cells known to express TMEM120A (adipocytes, HEK293 cells)

  • Use RT-qPCR to correlate protein detection with mRNA expression levels

• Fixation and permeabilization optimization:

  • Test different fixation methods (paraformaldehyde, methanol, glutaraldehyde)

  • Try graduated permeabilization protocols to balance epitope access with structural preservation

• Epitope retrieval techniques:

  • Heat-induced epitope retrieval (HIER)

  • Enzymatic epitope retrieval

  • Detergent-based unmasking

• Multiple antibody validation:

  • Use antibodies targeting different TMEM120A epitopes (N-terminal, C-terminal, specific domains)

  • Compare monoclonal vs. polyclonal antibody staining patterns

What strategies can address cross-reactivity between TMEM120A and its paralog TMEM120B in immunodetection assays?

TMEM120A has a paralog, TMEM120B, with sequence similarity that can potentially confound antibody specificity . To address this challenge:

Analysis of potential cross-reactivity:

• Sequence alignment analysis: Compare TMEM120A and TMEM120B sequences to identify unique and shared epitopes

• Expression pattern differentiation: TMEM120A and TMEM120B may have distinct tissue expression patterns that can help interpret results

Experimental approaches to ensure specificity:

• Knockout validation:

  • Test antibodies on TMEM120A-specific knockout samples

  • Create double knockouts (TMEM120A and TMEM120B) for comprehensive validation

• Isoform-specific detection:

  • Design primers for RT-qPCR that specifically amplify either TMEM120A or TMEM120B

  • Use results to correlate with protein detection patterns

• Recombinant protein testing:

  • Express recombinant TMEM120A and TMEM120B separately

  • Test antibody reactivity against each protein

  • Perform competition assays with purified proteins

• Epitope mapping:

  • Use peptide arrays or deletion constructs to identify the exact epitopes recognized by antibodies

  • Select antibodies targeting regions with minimal sequence homology between TMEM120A and TMEM120B

• Combined detection approach:

  • Use multiple antibodies targeting different epitopes

  • Confirm results with orthogonal methods (mass spectrometry, genetic tagging)

How can TMEM120A antibodies be utilized to elucidate this protein's role in adipocyte differentiation and metabolism?

TMEM120A has been implicated in adipocyte differentiation and metabolism . To investigate these functions:

Differentiation studies:

• Temporal expression analysis: Use TMEM120A antibodies to track protein expression during adipocyte differentiation stages

• Co-localization with differentiation markers: Perform dual immunostaining with TMEM120A antibodies and adipocyte differentiation markers

• Inducible knockdown/knockout systems: Create systems to modulate TMEM120A expression at specific time points during differentiation

Metabolic function investigations:

• Protein-protein interaction studies: Use TMEM120A antibodies for co-immunoprecipitation experiments to identify binding partners involved in metabolic pathways

• Subcellular fractionation: Isolate different cellular compartments and analyze TMEM120A distribution in response to metabolic challenges

• Post-translational modification profiling: Use modification-specific antibodies to detect changes in TMEM120A phosphorylation, ubiquitination, or other modifications under different metabolic conditions

Advanced experimental approaches:

• Proximity labeling: Use TMEM120A-BioID or APEX fusions combined with specific antibodies to map the protein's proximal interactome in adipocytes

• In situ metabolic enzyme activity: Develop assays to detect potential enzymatic activities of TMEM120A using its antibodies for localization

• Lipidomic analysis: Compare lipid profiles between wild-type and TMEM120A-deficient adipocytes to identify metabolic pathways affected

What novel research applications could leverage the recent structural insights into TMEM120A's CoA binding capability?

The discovery of TMEM120A's CoA binding capability opens new research avenues:

CoA-related metabolic studies:

• CoA transport investigation: Determine if TMEM120A facilitates CoA movement across membranes using radioactively labeled or fluorescent CoA analogs

• CoA sensing mechanisms: Examine if TMEM120A functions as a CoA sensor that triggers cellular responses to changes in CoA levels

• Metabolic enzyme activity: Investigate potential acyltransferase or related enzymatic functions similar to those of ELOVL proteins

Structure-guided antibody development:

• Conformation-specific antibodies: Develop antibodies that specifically recognize the CoA-bound or apo forms of TMEM120A

• Domain-specific antibodies: Create antibodies targeting specific functional domains identified in the structural studies

• Binding-pocket probes: Design chemical probes that can be used alongside antibodies to monitor the occupancy state of the CoA binding pocket

Therapeutic exploration:

• Small molecule screening: Use the CoA binding pocket structural information to design or screen for compounds that modulate TMEM120A function

• Antibody-based targeting: Develop antibodies that can modulate TMEM120A function in metabolic disorders

• Structure-function correlation in disease: Compare TMEM120A structure and function in normal versus disease states using specific antibodies

These advanced research applications build upon the recent structural insights and could significantly advance our understanding of TMEM120A's biological roles and potential as a therapeutic target.